Resources from the same session
Treatment of NSCLC Positive for ALK or ROS
Presenter: H. Errihani, MA
Session: Session 5 - Advanced NSCLC with Oncogenic Addiction
Resources:
Slides
Beyond EGFR, ALK, ROS: Other Molecular Alterations
Presenter: J. Bennouna, FR
Session: Session 5 - Advanced NSCLC with Oncogenic Addiction
Resources:
Slides